MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
Sakura Yamamura(Kurume University), Takuji Torimura(Omuta hospital), Dan Nakano(Kurume University), Tsubasa Tsutsumi(Kurume University), Keizo Anzai(Saga University), Mohammed Eslam(The University of Sydney), Hirokazu Takahashi, Shinobu Yoshinaga, Takumi Kawaguchi(Kurume University), Jacob George(University of Dundee)
Cited by 410
Related Papers
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
|Hepatology International|2020|841
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536